PAULYN HARRIS: Open Payments
NPI 1154801140 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 19 payments from 10 companies in 2025. Trend: 2023 $343 · 2024 $544 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $87 |
| Lilly USA, LLC | 4 | $86 |
| Astellas Pharma US Inc | 2 | $53 |
| Dexcom, Inc. | 2 | $53 |
| ACADIA Pharmaceuticals Inc | 1 | $40 |
| SHIELD THERAPEUTICS INC | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
| CeQur Corporation | 1 | $13 |
Products named: Veozah, Dexcom G6 Transmitter, MOUNJARO, DAYBUE, JARDIANCE, ACCRUFER, EVENITY, OTEZLA.
Industry payments across CA — which companies pay providers there.
